Huntsman Corp. of The Woodlands, TX, has announced that it has completed the acquisition of CVC Thermoset Specialties, a North American specialty chemical manufacturer serving the industrial composites, adhesives and coatings markets.
The Alberta Carbon Trunk Line (ACTL) system, the world’s newest — and said to be the largest capacity — carbon capture, utilization, and storage (CCUS) project, is now fully operational.
EarthRenew of Toronto has been selected to submit an international consortium project proposal by the governments of Canada and the United Kingdom (UK). The two governments are working together to foster and support collaborative industrial research and development (R&D) projects with a seemingly high potential for commercialization.
Mississauga, ON-based Rittal Systems has welcomed Franklin Empire to its distribution/partner network in Quebec. In 2017, Rittal also added Franklin Empire of Toronto to its network in Ontario.
Toronto-based Professional Engineers Ontario (PEO), the licensing and regulating body for professional engineers and engineering in the province, has installed Marisa Sterling, P.Eng., FEC, as its 101st president and eighth woman to lead its council during its virtual annual general meeting (AGM) on May 30.
Aztec Electrical Supply, a Rittal System Ltd. electrical and automation distributor based in Concord, ON, has enhanced its enclosure modification capabilities. Aztec has acquired a Perforex machining centre, which can be deployed for drilling, thread tapping, wiring and milling when machining enclosures and panels of all sizes.
Exhibitor invitations have been sent out and interested companies can now register as exhibitors at the industrial valves and fittings exhibition, Valve World Expo in Düsseldorf, Germany.
The International Society for Pharmaceutical Engineering (ISPE) of North Bethesda, MD, has announced that Thomas Hartman has been appointed as CEO and president. Hartman has a long history in the pharmaceutical industry, rising to the role of VP of GMP Operations, Biopharm CMC, for GlaxoSmithKline (GSK).
GlaxoSmithKline plc (GSK) of London, UK, and Songdo, South Korea-based Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s biopharmaceutical therapies.